AFFITECH A/S

Affitech A/S (‘the Company’) is a biopharmaceutical company dedicated to the discovery and development of fully human antibody therapeutics against cancer and other serious diseases. The Parent Company is mainly a holding company and the Group does not have any significant activities other than maintenance of out-license and collaboration agreements entered into in prior years. The Affitech A/S Group comprises the Parent Company Affitech A/S and its fully-owned subsidiaries Affitech Research AS (Norway) and Actigen Ltd. (UK) (together referred to as ‘the Group’).